Skip to main content
. 2020 Mar 2;77(17):3351–3367. doi: 10.1007/s00018-020-03492-0

Table 1.

Diagnostic criteria proposed by Pitt et al. to distinguish SMARD1 from other similar conditions and to facilitate the classification of the disease [81]

Clinical criteria Histopathological criteria EMG criteria
Low birth weight (< 3rd percentile) Reduced myelinated fiber diameter in sural nerve biopsiesa Evidence of acute or chronic distal denervation
Onset of symptoms within the first 3 months of life Slight evidence of progressive myelinated fiber degeneration in biopsies taken up to 3–4 months of age Evidence of significant slowing (< 70% of LLN) in one or more motor a/o sensory nerves
Unilateral or bilateral diaphragmatic weakness No evidence of regeneration or demyelination that can justify the reduction in fiber size
Ventilator dependence within < 1 month of onset associated with an inability to wean
No evidence of other dysmorphology or other conditions

LLN lower limit of normal range

aSince the thickness of the myelin sheath is appropriate for the axon size, its reduction in diameter originates from the axon, the size of which is similarly reduced